Moderna’s vaccine was authorized for emergency use in December, and as of Sunday, more than 151 million doses had been administered in the United States, according to data from the Centers for Disease Control and Prevention. Last week, Moderna announced that its vaccine appeared to be highly effective in teenagers and that it planned to apply for emergency use authorization for adolescents in June. Pfizer’s vaccine was authorized for use in 12- to 15-year-olds last month. Moderna’s full approval request comes as more than 50 percent of the U.S. population has received at least one dose of a vaccine, but the pace of vaccinations has dropped sharply since mid-April. “But those concerns are being allayed as they see more of their friends and acquaintances celebrating getting vaccinated.”Jan Hoffman contributed reporting.

Source: New York Times June 01, 2021 15:23 UTC